Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT05367089

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Led by Maastricht University Medical Center · Updated on 2023-05-17

252

Participants Needed

2

Research Sites

243 weeks

Total Duration

On this page

Sponsors

M

Maastricht University Medical Center

Lead Sponsor

Z

Zuyderland Medical Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to investigate the efficacy of Fluconazol versus L-Mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. Vaginal swabs will be analyzed after 1, 6 and 12 months. The study ends after 252 included patients completed the study.

CONDITIONS

Official Title

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women of at least 18 years old
  • At least 3 episodes of vulvovaginal candidiasis symptoms in the last year
  • Clinical and microbiological diagnosis of recurrent vulvovaginal candidiasis at consultation
  • Ability to understand, consent, and follow trial procedures
Not Eligible

You will not qualify if you...

  • Mixed vaginal infections
  • Pregnancy or planning pregnancy during the study
  • Use of systemic or topical antifungal medication in the 2 weeks before inclusion
  • Known allergy or contraindication to Fluconazole or honey
  • Candida resistant to Fluconazole
  • Breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Zuyderland Medical Centre

Heerlen, Netherlands

Actively Recruiting

2

MaastrichtUMC

Maastricht, Netherlands

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here